Watchlist Price Alert

PharmaCyte Biotech Inc. (PMCB)

NASDAQ: PMCB · Real-Time Price · USD

1.05

0.01 (0.96%)

At close: May 21, 2025, 1:03 PM

PharmaCyte Biotech Cash Flow Statement

Financials in USD. Fiscal year is May - April.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017	Apr 30, 2016
Net Income	333.76K	-4.32M	-4.24M	-3.55M	-3.83M	-4.07M	-6.83M	-4.44M	-6.06M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	674.69	645.41K	77.96K	370.83K	748.03K	705.68K	1.53M	1.02M	2.1M
Other Working Capital	37.8K	242.95K	-24.06K	-132.03K	203.39K	397.83K	-72.89K	-50.75K	-712.81K
Other Non-Cash Items	-2.78M	174.02K	34.85K	-4.87K	473.14K	316.54K	309.88K	107.5K	491.68K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	298.89K	-297.17K	9.04K	-145.61K	267.35K	167.1K	-85.87K	-21.16K	-873.5K
Operating Cash Flow	-2.15M	-3.79M	-4.12M	-3.33M	-2.34M	-2.88M	-5.08M	-3.34M	-4.35M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	62.85K	n/a	n/a	n/a	n/a
Common Stock Repurchased	-44.36M	-13.56M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	880.00	-50.8K	-62.44K	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	-10.71M	-13.56M	87.31M	4.64M	2.73M	2.34M	2.68M	4.88M	3.57M
Net Cash Flow	-17.86K	-17.36M	83.2M	1.31M	379.61K	-544.54K	-2.4M	1.54M	-778.91K
Free Cash Flow	-2.15M	-3.79M	-4.12M	-3.33M	-2.34M	-2.88M	-5.08M	-3.34M	-4.35M